Back
Crinetics Pharmaceuticals Stock Price Chart
Sponsored
CRNX
Sponsored
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
44
CRNX
Crinetics Pharmaceuticals
Last Price:
54.79
Seasonality Move:
9.3%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
Crinetics Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.96 | Sell |
20-day SMA: | 58.08 | Sell |
50-day SMA: | 54.8 | Sell |
200-day SMA: | 48.45 | Buy |
8-day EMA: | 58.09 | Sell |
20-day EMA: | 57.58 | Sell |
50-day EMA: | 55.57 | Sell |
200-day EMA: | 48.08 | Buy |
Crinetics Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.93 | Buy |
Relative Strength Index (14 RSI): | 41.37 | Sell |
Chaikin Money Flow: | -813700 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.75 - 59.71) | Sell |
Bollinger Bands (100): | (49.05 - 56.79) | Buy |
Crinetics Pharmaceuticals Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Crinetics Pharmaceuticals Stock
Is Crinetics Pharmaceuticals Stock a Buy?
- Crinetics Pharmaceuticals share price is 54.72 while CRNX 8-day simple moving average is 58.96, which is a Sell signal.
- The stock price of CRNX is 54.72 while Crinetics Pharmaceuticals 20-day SMA is 58.08, which makes it a Sell.
- Crinetics Pharmaceuticals 50-day simple moving average is 54.80 while CRNX share price is 54.72, making it a Sell technically.
- CRNX stock price is 54.72 and Crinetics Pharmaceuticals 200-day simple moving average is 48.45, creating a Buy signal.
CRNX Technical Analysis vs Fundamental Analysis
Sell
44
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy or a Sell?
-
Crinetics Pharmaceuticals stock is rated a Sell
The current Crinetics Pharmaceuticals [CRNX] share price is $54.72. The Score for CRNX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Crinetics Pharmaceuticals Stock Info
Market Cap:
5.07B
Price in USD:
54.72
Share Volume:
908.87K
Crinetics Pharmaceuticals 52-Week Range
52-Week High:
62.53
52-Week Low:
28.50
Sell
44
Crinetics Pharmaceuticals (CRNX)
is a Sell
Crinetics Pharmaceuticals Share Price Forecast
-
What is the Crinetics Pharmaceuticals stock price today?
The Crinetics Pharmaceuticals stock price is 54.72 USD today. -
Will CRNX stock go up or go down?
Crinetics Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Crinetics Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Crinetics Pharmaceuticals is overvalued.
Is Crinetics Pharmaceuticals Stock a Buy?
- Crinetics Pharmaceuticals share price is 54.72 while CRNX 8-day exponential moving average is 58.09, which is a Sell signal.
- The stock price of CRNX is 54.72 while Crinetics Pharmaceuticals 20-day EMA is 57.58, which makes it a Sell.
- Crinetics Pharmaceuticals 50-day exponential moving average is 55.57 while CRNX share price is 54.72, making it a Sell technically.
- CRNX stock price is 54.72 and Crinetics Pharmaceuticals 200-day simple moving average is 48.08, creating a Buy signal.
Fundamental Analysis of Crinetics Pharmaceuticals
Is Crinetics Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Crinetics Pharmaceuticals
Should I short Crinetics Pharmaceuticals stock?
- CRNX Moving Average Covergence Divergence (MACD) indicator is 0.93, suggesting Crinetics Pharmaceuticals is a Buy
- Crinetics Pharmaceuticals Relative Strength Index (RSI) is 41.37, which suggest Crinetics Pharmaceuticals is oversold
- The Bollinger Bands (25) for Crinetics Pharmaceuticals is (55.75 - 59.71), which suggest Crinetics Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Crinetics Pharmaceuticals is (49.05 - 56.79), which suggest Crinetics Pharmaceuticals is a Buy
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.